These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3583621)

  • 1. Effects of ticlopidine on metastasis production in mice bearing Lewis lung carcinoma.
    Fabra A; de Castellarnau C; Carretero F; Martínez E; Sancho MJ; Rutllant ML
    Invasion Metastasis; 1987; 7(1):53-60. PubMed ID: 3583621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 5-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine hydrochloride (Ticlopidine), a platelet aggregation inhibitor, on blood-borne metastasis.
    Kohga S; Kinjo M; Tanaka K; Ogawa H; Ishihara M; Tanaka N
    Cancer Res; 1981 Nov; 41(11 Pt 1):4710-4. PubMed ID: 7306988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of DN-9693, a new metastasis inhibitor, on murine hematogenous metastasis.
    Tanaka NG; Tohgo A; Ogawa H; Osada Y
    Anticancer Res; 1986; 6(4):543-8. PubMed ID: 3019218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of primary tumour, spontaneous metastases and recurrence of Lewis lung carcinoma (3LL) to flavone acetic acid (FAA, LM975).
    Desoize B; Carpentier Y; Guerrier D
    Anticancer Res; 1989; 9(6):1701-5. PubMed ID: 2627123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of lung metastasis progression in mice: role of growth kinetics of 3LL Lewis lung carcinoma and host immune reactivity.
    Gorelik E; Segal S; Feldman M
    J Natl Cancer Inst; 1980 Dec; 65(6):1257-64. PubMed ID: 6933271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyroservatide therapy for tumor growth, invasion and metastasis of Lewis lung carcinoma and human lung carcinoma A549.
    Zheng M; Lu R; Che X; Li J; Zhou C; Wang L; Xu Q; Cao H; Li Q; Yao Z
    Oncology; 2006; 70(6):418-26. PubMed ID: 17245103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimetastatic effect of flurbiprofen and other platelet aggregation inhibitors.
    Mamytbeková A; Rezábek K; Kacerovská H; Grimová J; Svobodová J
    Neoplasma; 1986; 33(4):417-21. PubMed ID: 3762804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with monoclonal antibody to a Lewis lung carcinoma-associated antigen: different effects on primary tumor and its metastases.
    Sacchi A; Kennel SJ; Apollonj C; Natali PG
    Cancer Treat Rep; 1985 Sep; 69(9):985-91. PubMed ID: 4028039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the metastasis of Lewis lung carcinoma by antibody against urokinase-type plasminogen activator in the experimental and spontaneous metastasis model.
    Kobayashi H; Gotoh J; Shinohara H; Moniwa N; Terao T
    Thromb Haemost; 1994 Apr; 71(4):474-80. PubMed ID: 8052966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Observations on the antimetastatic action of lysozyme in mice bearing Lewis lung carcinoma.
    Sava G; Ceschia V; Pacor S; Zabucchi G
    Anticancer Res; 1991; 11(3):1109-13. PubMed ID: 1888145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Avemar and Avemar + vitamin C on tumor growth and metastasis in experimental animals.
    Hidvégi M; Ráso E; Tömösközi-Farkas R; Paku S; Lapis K; Szende B
    Anticancer Res; 1998; 18(4A):2353-8. PubMed ID: 9703878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet effects of ticlopidine are reduced in experimental hypercholesterolemia.
    Hohlfeld T; Scharnowski F; Braun M; Schrör K
    Thromb Haemost; 1994 Jan; 71(1):112-8. PubMed ID: 7513092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of antiplatelet agents on pulmonary metastases.
    Bando H; Yamashita T; Tsubura E
    Gan; 1984 Mar; 75(3):284-91. PubMed ID: 6724229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
    Sola F; Farao M; Ciomei M; Pastori A; Mongelli N; Grandi M
    Invasion Metastasis; 1995; 15(5-6):222-31. PubMed ID: 8765197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma.
    Giraldi T; Sava G; Cuman R; Nisi C; Lassiani L
    Cancer Res; 1981 Jun; 41(6):2524-8. PubMed ID: 7237446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between primary tumor volume and lung metastasis in Lewis lung carcinoma (II). Tumor bed effect.
    Ohizumi Y; Maezawa H; Mori T
    Tokai J Exp Clin Med; 1987 Nov; 12(4):237-42. PubMed ID: 3503393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immune response against the alloantigens of the 3LL Lewis lung carcinoma prevents the growth of lung metastases, but not of local allografts.
    Isakov N; Feldman M; Segal S
    Invasion Metastasis; 1982; 2(1):12-32. PubMed ID: 6765248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of pulmonary metastasis of Lewis lung carcinoma by a glucan, Schizophyllan.
    Yamamoto T; Yamashita T; Tsubura E
    Invasion Metastasis; 1981; 1(1):71-84. PubMed ID: 6234252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice.
    Palumbo JS; Potter JM; Kaplan LS; Talmage K; Jackson DG; Degen JL
    Cancer Res; 2002 Dec; 62(23):6966-72. PubMed ID: 12460914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of progression of local tumor and pulmonary metastasis of the 3LL Lewis lung carcinoma by different histocompatibility requirements in mice.
    Isakov N; Feldman M; Segal S
    J Natl Cancer Inst; 1981 May; 66(5):919-26. PubMed ID: 6939934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.